Document ID: chunk:federal_register_of_legislation:F2025C00183:clause:1_73346
Version: federal_register_of_legislation:F2025C00183
Segment Type: clause
Provision Reference: sch 1 cl 73346
Character Range: 297027–298401

73346              Test of a pregnant patient, for the purpose of determining whether pathogenic cystic fibrosis transmembrane conductance regulator variants are present in the fetus in order to make or exclude a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder in the fetus, if:                                                                                                                                                                                                                                           500.00
                   (a) the fetus has:
                   (i) ultrasonic findings of echogenic gut; and
                   (ii) unknown familial cystic fibrosis transmembrane conductance regulator variants; and
                   (b) the patient's carrier status for pathogenic cystic fibrosis transmembrane conductance regulator variants is unknown; and
                   (c) the patient's reproductive partner's carrier status for pathogenic cystic fibrosis transmembrane conductance regulator variants is unknown; and
                   (d) the test is requested by a specialist or consultant physician who manages the treatment of the patient; and
                   (e) the test is not associated with a service to which item 73350 applies
                   Applicable only once per pregnancy